OPK Return on Tangible Equity | OPKO Health, Inc.

OPKO Health, Inc. (OPK) Return on Tangible Equity

2026-06-30: Return Tang Equity -32.38%.
2026-03-31: Return Tang Equity -94.21%.
2025-12-31: Return Tang Equity -84.40%.
2025-09-30: Return Tang Equity -63.06%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-32.38%
2026-03-31	-94.21%
2025-12-31	-84.40%
2025-09-30	-63.06%
2025-06-30	-69.00%
2025-03-31	-14.64%
2024-12-31	-24.24%
2024-09-30	-59.13%
2024-06-30	-117.95%
2024-03-31	-598.76%
2023-12-31	-372.69%
2023-09-30	-226.41%
2023-06-30	-134.31%
2023-03-31	-193.11%
2022-12-31	-230.82%
2022-09-30	-143.78%
2022-06-30	-72.82%
2022-03-31	-56.81%
2021-12-31	-3.58%
2021-09-30	11.55%
2021-06-30	11.44%
2021-03-31	21.42%
2020-12-31	5.93%
2020-09-30	-24.71%
2020-06-30	-47.84%
2020-03-31	-80.24%
2019-12-31	-76.10%
2019-09-30	-72.98%
2019-06-30	-57.11%
2019-03-31	-40.84%
2018-12-31	-32.11%
2018-09-30	-68.32%
2018-06-30	-69.57%
2018-03-31	-74.06%
2017-12-31	-68.95%
2017-09-30	-18.86%
2017-06-30	-15.57%
2017-03-31	-10.83%
2016-12-31	-8.37%
2016-09-30	-1.35%
2016-06-30	25.92%
2016-03-31	12.16%
2015-12-31	-5.02%
2015-09-30	-15.66%
2015-06-30	-58.31%
2015-03-31	-45.63%
2014-12-31	-30.92%
2014-09-30	-22.47%
2014-06-30	-23.59%
2014-03-31	-23.22%
2013-12-31	-19.88%
2013-09-30	-17.19%
2013-06-30	-31.32%
2013-03-31	-35.09%
2012-12-31	-197.65%
2012-09-30	-72.44%
2012-06-30	-25.06%
2012-03-31	-10.59%
2011-12-31	-2.89%
2011-09-30	-24.83%
2011-06-30	-22.71%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-84.40%
2024-12-31	-24.24%
2023-12-31	-372.69%
2022-12-31	-230.82%
2021-12-31	-3.58%
2020-12-31	5.93%
2019-12-31	-76.10%
2018-12-31	-32.11%
2017-12-31	-68.95%
2016-12-31	-8.37%
2015-12-31	-5.02%
2014-12-31	-30.92%
2013-12-31	-19.88%
2012-12-31	-197.63%
2011-12-31	-2.89%
2010-12-31	-181.77%
2009-12-31	-95.30%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
LB PHARMACEUTICALS INC (LBRX)	United States	$1.220B	-10.87
HARROW, INC. (HROW)	United States	$1.240B	-42.77
Damora Therapeutics, Inc. (DMRA)		$1.250B	-6.10
Jaguar Health, Inc. (JAGX)	United States	$1.184B
Latigo Biotherapeutics, Inc. (LTGO)	United States	$1.176B
Avalyn Pharma Inc. (AVLN)	United States	$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)	United States	$1.280B
Bicara Therapeutics Inc. (BCAX)	United States	$1.309B	-10.55
Seaport Therapeutics, Inc. (SPTX)	United States	$1.131B
Amphastar Pharmaceuticals, Inc. (AMPH)	United States	$1.116B	10.93